Viking Fund Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,000
Closed -$1.99M 128
2024
Q1
$1.99M Hold
7,000
0.36% 84
2023
Q4
$2.02M Buy
+7,000
New +$1.91M 0.39% 81
2020
Q3
Sell
-5,000
Closed -$1.18M 119
2020
Q2
$1.18M Sell
5,000
-1,000
-17% -$228K 0.44% 76
2020
Q1
$1.22M Sell
6,000
-2,500
-29% -$546K 0.53% 60
2019
Q4
$2.05M Sell
8,500
-1,500
-15% -$331K 0.58% 57
2019
Q3
$1.94M Hold
10,000
0.55% 54
2019
Q2
$1.84M Buy
+10,000
New +$1.79M 0.49% 62
2017
Q4
Sell
-8,500
Closed -$1.58M 126
2017
Q3
$1.58M Sell
8,500
-5,500
-39% -$975K 0.25% 79
2017
Q2
$2.41M Hold
14,000
0.37% 73
2017
Q1
$2.3M Buy
14,000
+7,000
+100% +$1.16M 0.31% 79
2016
Q4
$1.02M Buy
+7,000
New +$1.05M 0.13% 92

Other funds holding AMGN

Viking Fund Management's AMGN Position: Q2 2024 in Review

Viking Fund Management sold out of Amgen (AMGN) in Q2 2024, closing a stake of 7,000 shares — an estimated $1.99M sold.

Viking Fund Management first reported a position in AMGN in Q4 2016 and held it in 11 quarters. The position peaked at $2.41M in Q2 2017. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Viking Fund Management reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Viking Fund Management sold 7,000 Amgen shares in Q2 2024, an estimated $1.99M.
  • Viking Fund Management first reported a position in Amgen in Q4 2016 and held it in 11 quarters.
  • Viking Fund Management's Amgen position peaked at $2.41M in Q2 2017.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Viking Fund Management's 13F filing for Q2 2024, filed 16 Jul 2024.